|4Jan 30, 4:34 PM ET

ICOS CORP 4

4 · ICOS CORP · Filed Jan 30, 2007

Insider Transaction Report

Form 4
Period: 2007-01-29
Transactions
  • Disposition to Issuer

    Common Stock

    2007-01-29$34.00/sh37,000$1,258,0000 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-01-29$11.14/sh12,000$133,6800 total
    Exercise: $22.86From: 2005-05-04Exp: 2015-05-03Common Stock (12,000 underlying)
Footnotes (3)
  • [F1]Disposed of pursuant to the Merger Agreement under which Eli Lilly and Company ("Eli Lilly") acquired the Issuer ("Merger") and which provides for the cancellation of shares of common stock of the Issuer in exchange for $34.00 per share (the "Merger Consideration). Includes 7,000 shares of unvested restricted stock.
  • [F2]Vests in two equal amounts as of each of the next two annual stockholders' meetings of the Issuer following the grant date indicated, assuming continued service on the Board of Directors.
  • [F3]All options were cancelled pursuant to the Merger Agreement in exchange for cash consideration equal to the Merger Consideration less the exercise price per share.

Documents

1 file
  • 4
    rrd142526.xmlPrimary

    FORM 4 - SCHULER